share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:擬議出售證券
美股SEC公告 ·  07/10 16:45
Moomoo AI 已提取核心訊息
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 07/10/2024, with an aggregate market value of $108,575.69. The shares were acquired through stock option exercises on 06/13/2023 and 06/14/2023, with a total of 15,000 shares obtained from the issuer for a cash payment. This planned sale follows a series of transactions over the past three months, where a total of 93,124 shares were sold for gross proceeds of approximately $755,664.65.
Recursion Pharmaceuticals, Inc. officer Secora Michael is set to sell 15,000 Class A shares on 07/10/2024, with an aggregate market value of $108,575.69. The shares were acquired through stock option exercises on 06/13/2023 and 06/14/2023, with a total of 15,000 shares obtained from the issuer for a cash payment. This planned sale follows a series of transactions over the past three months, where a total of 93,124 shares were sold for gross proceeds of approximately $755,664.65.
Recursion Pharmaceuticals, Inc.的高管Secora Michael計劃於2024年7月10日出售15000 Class A股,總市值達到$108,575.69。這些股票是通過2023年6月13日和6月14日兩次行權方式獲取的,股票發行方以現金方式售出了總共15000股。這次預計出售是在過去三個月內一系列交易之後進行的。在這期間進行了總共93124股的賣出,總收益約爲$755,664.65。
Recursion Pharmaceuticals, Inc.的高管Secora Michael計劃於2024年7月10日出售15000 Class A股,總市值達到$108,575.69。這些股票是通過2023年6月13日和6月14日兩次行權方式獲取的,股票發行方以現金方式售出了總共15000股。這次預計出售是在過去三個月內一系列交易之後進行的。在這期間進行了總共93124股的賣出,總收益約爲$755,664.65。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息